Kaitlyn Kosko

DocwireNews

Base excision repair-related long noncoding RNAs (BERLncs) may provide valuable clinical decision-making insight for clinicians who treat patients with lung adenocarcinoma.Junzheng Zhang, PhD, and colleagues conducted a study in China in which they developed a risk score model for 19 BERLncs. Patients included in the study were divided into a high-risk cohort and a low-risk cohort. Disparities in tumor mutation burden (TMB), immune infiltration, tumor immune dysfunction and exclusion (TIDE) score, chemosensitivity, and immune checkpoint gene expression were investigated between the cohorts using comparative analyses.The high-risk cohort was associated with significantly lower OS compared with the low-risk cohort. Moreover, high-risk patients demonstrated elevated TMB, diminished TIDE scores, and an immunosuppressive tumor microenvironment. Patients in the low-risk cohort showed potential benefits from immunotherapy.In addition, the BERLncs risk model identified potential anticancer agents, according to study findings.Since lung adenocarcinoma is the most common type of lung cancer, the risk model shows promise as a prognostic biomarker for patients with the disease, &ldquo;providing valuable insights for clinical decision-making, therapeutic strategies, and understanding of underlying biological mechanisms,&rdquo; the authors wrote.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

BERLncs May Aid in Clinical Decision-Making for Patients With Adenocarcinoma

Lung Cancer

BERLncs may provide valuable clinical decision-making insight for clinicians who treat patients with lung adenocarcinoma.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe